Targeting RAS-ERK pathway alterations with MEK inhibitors to improve chemosensitivity in high grade serous ovarian cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting RAS-ERK pathway alterations with MEK inhibitors to improve chemosensitivity in high grade serous ovarian cancers

Published:2023-11 Issue: Volume:178 Page:69-79
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Nguyen Nancy T.,Raetz Alan,Montoya Dennis,Schilling Vincent,Tong Caili,Brooks Rebecca A.,Leiserowitz Gary,Chien Jeremy

Funder

U.S. Department of Defense

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference27 articles.

1. Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics;Prat;Hum. Pathol.,2018

2. Frontline treatment of epithelial ovarian cancer;Goh;Asia Pac. J. Clin. Oncol.,2015

3. Management of platinum-resistent relapsed epithelial ovarian cancer and new drug perspectives;Pujade-Lauraine;J. Clin. Oncol.,2019

4. The importance of Ras in drug resistance in cancer;Healy;Br. J. Pharmacol.,2022

5. Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity;Lee;Int. J. Mol. Sc.,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effekte der RAS-ERK-Signalweg-Blockade auf die Platinsensitivität bei HGSOC;Geburtshilfe und Frauenheilkunde;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP